BioAge Labs Successfully Closes IPO and Concurrent Private Placement
BioAge Labs Successfully Closes IPO and Concurrent Private Placement RICHMOND, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) Introduction BioAge Labs, Inc. (“BioAge”) (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of aging, today announced the closing of its upsized initial public offering of 12,650,000…